PRESS RELEASE published on 11/06/2024 at 07:30, 1 year 10 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs en novembre 2024. Découvrez les événements à venir et les programmes de thérapie de l'entreprise Biotechnologie Conférences Investisseurs Événements Sensorion Thérapies Auditives
BRIEF published on 09/20/2024 at 07:35, 1 year 11 months ago Sensorion dévoile de nouvelles avancées cliniques prometteuses Biotechnologie Essais Cliniques Thérapie Génique Perte Auditive Petite Molécule
BRIEF published on 09/20/2024 at 07:35, 1 year 11 months ago Sensorion Unveils Promising New Clinical Advances Biotechnology Clinical Trials Gene Therapy Hearing Loss Small Molecule
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 11 months ago Informations privilégiées / Autres communiqués Sensorion annonce de nouvelles données cliniques positives lors du Congrès Mondial d'Audiologie à Paris concernant les programmes de thérapie génique et de petite molécule Thérapie Génique Sensorion Données Cliniques Petite Molécule Congrès Mondial D'Audiologie
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 11 months ago Inside Information / Other news releases Sensorion announces positive clinical data on gene therapy and small molecule programs at World Congress of Audiology, Paris. Details by key medical professionals Clinical Data Gene Therapy Sensorion World Congress Of Audiology Small Molecule
BRIEF published on 09/18/2024 at 07:35, 1 year 11 months ago Sensorion Reports First Half 2024 Financial Results and Clinical Advances Clinical Trials Gene Therapy 2024 Financial Results Sensorion Hearing Loss Therapies
BRIEF published on 09/18/2024 at 07:35, 1 year 11 months ago Sensorion annonce ses résultats financiers et ses avancées cliniques pour le premier semestre 2024 Essais Cliniques Thérapie Génique Résultats Financiers 2024 Sensorion Thérapies Pour La Perte Auditive
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 11 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report Sensorion reports 2024 first half results including progress on SENS-501 and SENS-401 programs. Cash position strong at €87m. Future milestones and financial highlights outlined Sensorion Hearing Loss SENS-401 SENS-501 2024 Results
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 11 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel Sensorion publie ses résultats du premier semestre 2024 et fait le point sur ses activités. Premières données cliniques de SENS-501 et SENS-401 au Congrès Mondial d'Audiologie Résultats Premier Semestre Audiologie Sensorion Clinique
BRIEF published on 09/12/2024 at 07:35, 1 year 11 months ago Sensorion to Present at 59th Inner Ear Biology Workshop Conference Sensorion Hearing Loss Inner Ear Biology Proteomics
Published on 09/08/2026 at 01:45, 1 hour 44 minutes ago Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 2 days 23 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 3 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 4 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 4 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/07/2026 at 19:19, 8 hours 10 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Sales and Adjusted EBIT in Q2 2026/27 above prior-year level – FY outlook maintained
Published on 09/07/2026 at 19:00, 8 hours 29 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 août 2026 au 4 septembre 2026
Published on 09/07/2026 at 18:42, 8 hours 47 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/07/2026 at 18:00, 9 hours 29 minutes ago E-PANGO: e-Pango organise un webinaire avec ses actionnaires
Published on 09/07/2026 at 17:45, 9 hours 44 minutes ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 09/07/2026 at 19:00, 8 hours 29 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 8 hours 29 minutes ago Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 9 hours 24 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 9 hours 24 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026
